Expert Discusses When to Perform PSMA PET Imaging for Metastatic CRPC
Daniel J. George, MD, discusses why he considers using prostate-specific membrane antigen imaging early in treatment of patients with castration-resistant prostate cancer.
Cabazitaxel Impacts Sequencing Strategies in Prostate Cancer
Daniel J. George, MD, discusses how cabazitaxel can impact the sequencing approaches physicians use to treat patients with metastatic castration-resistant prostate cancer.